Williams Sarah Joanne
SEC CIK 2108922 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | Principal Accounting Off | 66.3K | — | $3,025 | 4 | 2026-02-20 | 2026-09-01 |
Most active insiders at ANTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Readnour Robin Shane | Dir | — | $316.7K |
| 2 | Eizen Joshua M | See Remarks | — | $52.9K |
| 3 | FitzPatrick Margaret M | Dir | $11.6K | — |
| 4 | Chanda Sanjay | Chief Development Off | — | $9,311 |
| 5 | Day Lucy | CFO | — | $8,862 |
| 6 | Prior Stephen David | Chief Strategy Off | — | $7,363 |
| 7 | Williams Sarah Joanne | Principal Accounting Off | — | $3,025 |
| 8 | Trenor Cameron C. III | Chief Medical Off | — | — |
| 9 | Marks Gilbert Lynn | Dir | — | — |
| 10 | Martin Patricia A. | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-04 16:25 | 2026-09-01 | ANTX | AN2 Therapeutics, Inc. | Williams Sarah Joanne | Principal Accounting Off | S - Sale | $5.53 | -272 | 66.3K | -0.4% | -$1,504 | |
| 2026-06-02 16:31 | 2026-05-29 | ANTX | AN2 Therapeutics, Inc. | Williams Sarah Joanne | Principal Accounting Off | S - Sale | $4.43 | -265 | 66.6K | -0.4% | -$1,174 | |
| 2026-03-05 | 2026-03-03 | ANTX | AN2 Therapeutics, Inc. | Williams Sarah Joanne | Principal Accounting Off | S - Sale | $1.06 | -327 | 66.8K | -0.5% | -$346.62 | |
| 2026-02-23 | 2026-02-20 | ANTX | AN2 Therapeutics, Inc. | Williams Sarah Joanne | Principal Accounting Off | A - Grant | $0.00 | +48.4K | 67.2K | +257% | $0 |
Purchase Sale Sale after option exercise All abbreviations